#Japan #Tokyo #Wemental #EPNextS #Logos Science

Introduction to Wemental

In a world increasingly plagued by workplace stress, mental health care applications like Wemental offer a lifeline. Developed collaboratively by EPNextS Corporation, headquartered in Shinjuku, Tokyo, and Logos Science Corporation, a subsidiary based in Minato, Tokyo, Wemental is rooted in the principles of Cognitive Behavioral Therapy (CBT). This innovative app has recently garnered attention for its acceptance into a government subsidy program aimed at advancing mental health services in Japan.

Context and Importance of Mental Health

Japan has reached an alarming juncture, with over 80% of workers reporting significant anxiety and stress related to their jobs, according to a Labor and Welfare Ministry survey. This epidemic of workplace stress not only threatens the wellbeing of workers but also hampers motivation and productivity, leading to higher rates of resignation and absenteeism. Consequently, fostering and enhancing the mental health of employees has become increasingly crucial for organizations.

The government’s subsidy program aims to support the development and effective evaluation of Digital Mental Health services (DMH) utilizing advanced technologies like AI, VR, and chatbots. This initiative is designed to help businesses scale their investments in employee mental health to combat the ongoing crisis effectively.

Features of Wemental

Wemental integrates CBT principles, guided by the research of Professor Hiroaki Kumano of Waseda University’s Applied Neuroscience Institute. The app functions by allowing users to self-assess stress levels and analyze physiological stress indicators through voice biomarkers. Furthermore, it provides personalized training based on the identified stress types.

Key achievements that led to Wemental's approval for the subsidy include:

• - Integration of scientifically-backed CBT strategies into practical app features, promoting early intervention and preventive approaches.
• - Utilization of patented technology (Pat. No. 7487872) to deliver tailored CBT-based care to individual users.
• - Inclusion of pulse surveys that visualize psychological stress while measuring less apparent physiological stress through voice biomarkers, aiding in mental health prevention.
• - Demonstrated improvements in subjective and physiological stress through concept proofs and feasibility studies, with plans for quantitative evaluations of work performance as well.

Collaborative Efforts and Future Directions

The partnership between EPS Holdings, a pioneer in the Clinical Research Organization (CRO) field, and Logos Science, established in 2022, has been instrumental in advancing mental health solutions. Together, they aim to enhance Wemental’s features and optimize user experience, focusing on the development of evidence-based support systems for an array of businesses, particularly small and medium enterprises.

Starting November 2024, EPNextS will inherit the application development framework, ensuring continuity and emphasis on functional enhancements through academia-industry collaborations. The blending of healthcare insights gained by EPNextS in pharmaceuticals and medical devices, together with Logos Science’s therapeutic programs, targets sustainable employment practices and productivity enhancement across various sectors.

The Vision for Mental Wellbeing

As both companies ramp up their efforts to further develop Wemental, they remain committed to delivering innovative mental health support to many organizations in need. The fusion of advanced technology and scientific research aims to empower individuals facing stress and mental health challenges, contributing towards creating a society with improved wellbeing.

In conclusion, Wemental is poised not only to assist in addressing the mental health crisis in Japan but potentially set a benchmark for similar applications globally. As societal awareness of mental health continues to evolve, Wemental stands at the forefront of this vital movement, equipping workers with the necessary tools to thrive in stressful environments.

About the Companies

EPNextS Corporation

Founded in 1991, EPNextS Corporation is a leader in the healthcare solution industry, particularly in clinical research and healthcare services. With a workforce of approximately 7,000 employees, EPNextS takes pride in its diverse range of services, which include clinical trials and marketing support, setting a new standard for healthcare solutions.

Logos Science Corporation

Established in 2022, Logos Science focuses on developing applications and systems aimed at addressing stress-related disorders and mental health care. Their mission is to create a society free from suffering through scientific understanding and technological innovation, enhancing the general wellbeing of the population.